Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis girds for rival Regeneron eye drug
Reuters
Friday, May 13, 2011 - 10:42am
tags:
Regeneron, Novartis, Lucentis, VEGF Trap-Eye, age-related macular degeneration
Amarin Spread Sees Good Prognosis
Seeking Alpha
Friday, May 13, 2011 - 10:40am
tags:
Amarin
J&J's Risperdal Charges Could Cost $1 Billion
TheStreet.com
Friday, May 13, 2011 - 10:39am
tags:
JNJ, Risperdal, off-label, antipsychotics
Big Pharma Bets on a Novel Cancer Cure
Bloomberg Businessweek
Friday, May 13, 2011 - 10:38am
tags:
cancer, Big Pharma, epigenetics, GSK, Eli Lilly, Novartis
Eisai’s Full-Year Aricept Sales Fell 10% to 290 Billion Yen
Bloomberg
Friday, May 13, 2011 - 10:37am
tags:
earnings, Eisai
Pfizer Sets Aside $772 Million, Settles Third of Prempro Cases
Bloomberg
Friday, May 13, 2011 - 10:12am
tags:
Prempro, Wyeth, Pfizer, settlements
GSK, AZ join hands to create new center for collaborative drug research
Fierce Biotech
Thursday, May 12, 2011 - 12:09pm
tags:
GSK, AstraZeneca, R&D, inflammation
Pharma CEOs talk tough about unproductive R&D spending
Fierce Biotech
Thursday, May 12, 2011 - 11:59am
tags:
R&D, Pharma CEOs
Amgen CEO Pay & Performance: A ‘Disconnect’
Pharmalot
Thursday, May 12, 2011 - 11:53am
tags:
Amgen, executive pay, Kevin Sharer, Pharma CEOs
Shire eyes huge sales from new Vyvanse uses
Reuters
Thursday, May 12, 2011 - 11:52am
tags:
Vyvanse, Shire, schizophrenia, depression, ADHD
Drugmakers gear up to copy biotech drugs in U.S.
Reuters
Thursday, May 12, 2011 - 11:50am
tags:
Big Pharma, biosimilars, Novartis, Sanofi
Glaxo, Gilead AIDS Drugs Slash HIV Transmission by 96%
Bloomberg
Thursday, May 12, 2011 - 11:48am
tags:
GSK, Gilead Sciences, AIDS, HIV
Ariad and Exelixis Look to Shine at Upcoming Trade Show
Seeking Alpha
Thursday, May 12, 2011 - 11:48am
tags:
Ariad Pharmaceuticals, Exelixis, ridaforolimus, cancer, cabozantinib
Sunesis posts 1Q profit on Millennium payment
Yahoo/AP
Thursday, May 12, 2011 - 11:46am
tags:
Sunesis, earnings, Millennium
Momenta Pharma: On a Roll in 2011
Seeking Alpha
Thursday, May 12, 2011 - 8:10am
tags:
Momenta
Ironwood Pharmaceuticals takes bigger 1Q loss
Yahoo/AP
Thursday, May 12, 2011 - 8:09am
tags:
earnings, Ironwood
Novartis Unit Profiting From J&J Recalls, CFO Tells Reuters
Bloomberg
Thursday, May 12, 2011 - 8:08am
tags:
Novartis, JNJ, recalls
Takeda Said to Be in Talks to Acquire Swiss Drugmaker Nycomed
Bloomberg
Wednesday, May 11, 2011 - 8:20pm
tags:
M&A, Nycomed, Takeda
Abbott's Lucky Number
Motley Fool
Wednesday, May 11, 2011 - 8:17pm
tags:
Humira, Abbott Laboratories, Remicade, ulcerative colitis, JNJ, Merck
Auxilium Misses, Revises Outlook
Yahoo/Zacks.com
Wednesday, May 11, 2011 - 8:16pm
tags:
earnings, Auxilium

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.